Lv3
366 积分 2025-05-28 加入
Manufacturing of CRISPR-edited primary mouse CAR T cells for cancer immunotherapy
2天前
已完结
Organoids-on-a-chip
3天前
已完结
Personalized pharmacokinetic-pharmacodynamic guided therapy via an induced pluripotent stem cell-derived multi-organoid platform in NF1-mutant breast cancer
3天前
已完结
A Vascularized Lung Tumoroid‐on‐Chip Model for the Accurate Assessment of Anti‐Invasion Agents
3天前
已完结
Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche
5天前
已完结
The tumor microenvironment’s role in the response to immune checkpoint blockade
7天前
已完结
Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial
7天前
已完结
Discovery of predictive biomarkers for cancer therapy through computational approaches
7天前
已完结
The next generation of immunotherapies for lung cancers
7天前
已完结
Patient-derived malignant effusion organoids guide tailored therapy and dissect third-generation EGFR-tyrosine kinase inhibitor resistance mechanisms in lung cancer
12天前
已关闭
皖公网安备34019202002308
